HomeOwner SearchCategory Search
Visit USCOHuman tumor antigens and specific tumor therapy proceedings of a Cetus-Triton Biosciences-U C L A symposium, held at Keystone, Colorado, April 23-30, 1988 editors, Richard S. Metzgar, Malcolm S. Mitchell
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
Human tumor antigens and specific tumor therapy proceedings of a Cetus-Triton Biosciences-U C L A symposium, held at Keystone, Colorado, April 23-30, 1988 editors, Richard S. Metzgar, Malcolm S. Mitchell
Status
Published
on 13 Jun 2007
Year of Creation
1988
Copyright Claimant
Alan R. Liss, Inc
Registration Number
TX0002569081
on 13 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0002569081) dated 13 Jun 2007, pertains to an electronic file (eService) titled "Human tumor antigens and specific tumor therapy proceedings of a Cetus-Triton Biosciences-U C L A symposium, held at Keystone, Colorado, April 23-30, 1988 editors, Richard S. Metzgar, Malcolm S. Mitchell" created in 1988. The copyright holder is Alan R. Liss, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Alan R. Liss, Inc.
Application Details
Registration Number
TX0002569081
Registration Date
6/13/2007
Year of Creation
1988
Place of First Publication
New York
Publisher Name
A.R. Liss
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Cetus Corporation Triton Biosciences, Inc University of California, Los Angeles Alan R. Liss, Inc
Physical Description
366 p
Series Statement
UCLA symposia on molecular and cellular biology v. 99
Corporate Authors
Statements
Author Statement: compilation and editorial revisions: Alan R. Liss, Inc., employer for hire
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.